Love Pharma Initiates First Steps Towards a Strategic Alliance with Starton Therapeutics with Investment in this Biotech Leader Pharmaceutical Investing
Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research Pharmaceutical Investing
Bristol Myers Squibb to Report Results for Third Quarter 2022 on October 26, 2022 Pharmaceutical Investing
FDA Grants Breakthrough Therapy Designation to Pfizer's Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women Pharmaceutical Investing
Kite's CAR T-cell Therapy Tecartus® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia Pharmaceutical Investing
Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action Pharmaceutical Investing
Bristol Myers Squibb to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Pharmaceutical Investing
Merck to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Pharmaceutical Investing
Bristol Myers Squibb Research at ESMO Congress 2022 Highlights Depth of Development Program Across Early- and Late-Stages of Cancer Pharmaceutical Investing
New TROPiCS-02 Data in HR+/HER2- Metastatic Breast Cancer Patients Demonstrates Progression-Free Survival Benefit of Trodelvy® Regardless of Their HER2 Status Pharmaceutical Investing
